| Product NDC: | 61748-200 |
| Proprietary Name: | CICLOPIROX |
| Non Proprietary Name: | CICLOPIROX |
| Active Ingredient(s): | 80 mg/mL & nbsp; CICLOPIROX |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61748-200 |
| Labeler Name: | VersaPharm Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078975 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100320 |
| Package NDC: | 61748-200-06 |
| Package Description: | 6.6 mL in 1 BOTTLE, WITH APPLICATOR (61748-200-06) |
| NDC Code | 61748-200-06 |
| Proprietary Name | CICLOPIROX |
| Package Description | 6.6 mL in 1 BOTTLE, WITH APPLICATOR (61748-200-06) |
| Product NDC | 61748-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CICLOPIROX |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20100320 |
| Marketing Category Name | ANDA |
| Labeler Name | VersaPharm Incorporated |
| Substance Name | CICLOPIROX |
| Strength Number | 80 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |